Chantal Barin‐Le Guellec

Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design

Stéphanie Leroux, M. Turner, Chantal Barin‐Le Guellec et al. · Clinical Pharmacokinetics · 2015 · 78 citations

Pharmacokinetic Studies, Therapeutic Drug Monitoring, Neonatology +7

Toxicities associated with chemotherapy regimens containing a fluoropyrimidine: A real-life evaluation in France

Chantal Barin‐Le Guellec, Claire Lafay‐Chebassier, Isabelle Ingrand et al. · European Journal of Cancer · 2019 · 62 citations · Full text

Medicine, Metronomic Therapy, Pharmacology +9

Pharmacokinetics and safety of fluconazole and micafungin in neonates with systemic candidiasis: a randomized, open‐label clinical trial

Stéphanie Leroux, Évelyne Jacqz-Aigrain, Valery Élie et al. · British Journal of Clinical Pharmacology · 2018 · 41 citations · Full text

Endogenous Metabolites‐Mediated Communication Between OAT1/OAT3 and OATP1B1 May Explain the Association Between <i>SLCO1B1</i> SNPs and Methotrexate Toxicity

David Martı́nez, Kienana Muhrez, Jean‐Baptiste Woillard et al. · Clinical Pharmacology & Therapeutics · 2017 · 37 citations

Systems Biology, Oatp1b1 May Explain, Allergy +15

Endogenous metabolites that are substrates of organic anion transporter’s (OATs) predict methotrexate clearance

Kienana Muhrez, Isabelle Benz‐de Bretagne, Lydie Nadal‐Desbarats et al. · Pharmacological Research · 2016 · 30 citations

Biochemistry, Medicine, Endogenous Metabolites +7